Neuropace shares owned by Tower Research Capital
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $33k | 4.4k | 7.56 |
| 2024-03-31 | $50k | 3.8k | 13.20 |
| 2023-06-30 | $404 | 90 | 4.49 |
| 2023-03-31 | $4.0k | 784 | 5.10 |
| 2022-12-31 | $9.0k | 5.7k | 1.58 |
| 2022-09-30 | $19k | 5.0k | 3.83 |
| 2022-03-31 | $13k | 1.6k | 7.97 |
| 2021-12-31 | $11k | 1.1k | 9.77 |
| 2021-09-30 | $9.0k | 557 | 16.16 |
| 2021-06-30 | $32k | 1.3k | 23.83 |